China Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . China SXT Pharmaceuticals
SXTC Stock  USD 2.80  0.18  6.87%   
China SXT financial statements provide useful quarterly and yearly information to potential China SXT Pharmaceuticals investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on China SXT financial statements helps investors assess China SXT's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting China SXT's valuation are summarized below:
Gross Profit
554 K
Profit Margin
(1.61)
Market Capitalization
1.3 M
Enterprise Value Revenue
0.4132
Revenue
1.9 M
We have found one hundred twenty available fundamental signals for China SXT Pharmaceuticals, which can be analyzed and compared to other ratios and to its rivals. Investors should ensure to validate all of China SXT's prevailing performance against the performance from 2010 to 2025 to make sure the company is sustainable down the road. As of March 19, 2025, Market Cap is expected to decline to about 12.6 M. In addition to that, Enterprise Value is expected to decline to about 2.3 M

China SXT Total Revenue

1.65 Million

Check China SXT financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among China SXT's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 4.4 K or Interest Expense of 758.9 K, as well as many indicators such as Price To Sales Ratio of 6.53, Dividend Yield of 0.0 or PTB Ratio of 0.9. China financial statements analysis is a perfect complement when working with China SXT Valuation or Volatility modules.
  
Check out the analysis of China SXT Correlation against competitors.

China SXT Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets21.9 M26.6 M16.2 M
Slightly volatile
Other Current Liabilities6.5 M4.6 M4.6 M
Slightly volatile
Total Current Liabilities11.1 M10.2 M8.7 M
Slightly volatile
Total Stockholder Equity10.7 M16 M7.4 M
Slightly volatile
Net Tangible Assets19.8 M18.8 M8.3 M
Slightly volatile
Accounts Payable1.4 M1.2 M2 M
Slightly volatile
Cash9.2 M13.9 M6.2 M
Slightly volatile
Cash And Short Term Investments9.2 M13.9 M6.2 M
Slightly volatile
Net Receivables1.2 M1.2 M3.3 M
Very volatile
Capital Surpluse9.6 M9.1 M4.9 M
Slightly volatile
Inventory799.6 K728.8 K1.2 M
Slightly volatile
Other Current Assets7.5 K7.9 K273.2 K
Very volatile
Other Stockholder Equity42.6 M40.6 M14.9 M
Slightly volatile
Total Liabilities11.2 M10.6 M8.8 M
Slightly volatile
Total Current Assets16.1 M16.4 M12 M
Slightly volatile
Short Term Debt1.9 M2.7 M1.4 M
Slightly volatile
Intangible Assets34.3 K17.2 K40.3 K
Slightly volatile
Common Stock5.3 M5 M998 K
Slightly volatile
Property Plant Equipment1.5 M1.8 M1.1 M
Slightly volatile
Short and Long Term Debt Total2.2 M3 M1.5 M
Slightly volatile
Property Plant And Equipment Net482.8 K508.2 K925.1 K
Slightly volatile
Current Deferred Revenue192.3 K168.9 K362.5 K
Slightly volatile
Non Current Assets Total6.5 M10.2 M4.2 M
Slightly volatile
Non Currrent Assets Other5 M9.6 M3.4 M
Slightly volatile
Common Stock Total Equity74.9 K71.4 K38.2 K
Slightly volatile
Common Stock Shares Outstanding1 M997.5 K209.7 K
Slightly volatile
Liabilities And Stockholders Equity23.8 M26.6 M16 M
Slightly volatile
Property Plant And Equipment Gross2.4 M3.6 M1.6 M
Slightly volatile
Short and Long Term Debt2.1 M2.6 M1.4 M
Slightly volatile
Other Assets11.4 M10.9 M3.8 M
Slightly volatile
Short Term Investments78.4 K88.2 K96.2 K
Slightly volatile
Net Invested Capital15.7 M18.8 M10 M
Slightly volatile
Net Working Capital6.1 M6.1 M3.9 M
Slightly volatile
Other Liabilities33.4 K37.5 K40.9 K
Slightly volatile
Capital Stock5.3 M5 M999.4 K
Slightly volatile
Long Term Debt76.4 K134.7 K58.5 K
Slightly volatile

China SXT Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income4.4 K4.7 K24.2 K
Slightly volatile
Selling General Administrative2.9 M3 M2 M
Slightly volatile
Total Revenue1.6 M1.7 M3.8 M
Slightly volatile
Gross Profit473.6 K498.6 K1.5 M
Very volatile
Cost Of Revenue1.8 M1.2 M2.4 M
Slightly volatile
Total Operating Expenses4.1 M3.5 M3.7 M
Slightly volatile
Depreciation And Amortization255.8 K233.7 K184.1 K
Slightly volatile
Selling And Marketing Expenses717.9 K390.2 K572 K
Slightly volatile
Other Operating Expenses6.5 M5.1 M4.9 M
Slightly volatile
Reconciled Depreciation276.7 K233.7 K198.6 K
Slightly volatile
Research Development147.4 K165.8 K180.7 K
Slightly volatile

China SXT Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow21 M20 M6.6 M
Slightly volatile
Depreciation238.2 K233.7 K179.1 K
Slightly volatile
Capital Expenditures6 K6.4 K192.6 K
Very volatile
End Period Cash Flow9.2 M13.9 M6.2 M
Slightly volatile
Stock Based Compensation301 K316.9 K676.2 K
Pretty Stable
Sale Purchase Of Stock5.2 M5.8 M6.4 M
Slightly volatile
Dividends Paid1.9 M2.1 M2.3 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio6.536.8793.6437
Slightly volatile
PTB Ratio0.90.9556.72
Slightly volatile
Days Sales Outstanding327229390
Very volatile
Book Value Per Share17.5518.47721
Slightly volatile
Average Payables1.8 M1.7 M1.7 M
Slightly volatile
Stock Based Compensation To Revenue0.20.210.7274
Slightly volatile
Capex To Depreciation0.0380.041.3746
Pretty Stable
PB Ratio0.90.9556.72
Slightly volatile
Inventory Turnover2.541.952.1103
Slightly volatile
Days Of Inventory On Hand136194183
Slightly volatile
Payables Turnover1.431.241.2131
Pretty Stable
Sales General And Administrative To Revenue0.721.230.6669
Slightly volatile
Average Inventory1 M771.1 K1.1 M
Slightly volatile
Capex To Revenue0.0040.00420.0376
Pretty Stable
Cash Per Share15.216.0595
Slightly volatile
Days Payables Outstanding237306313
Slightly volatile
Intangibles To Total Assets9.0E-40.0010.0042
Slightly volatile
Current Ratio1.191.441.329
Slightly volatile
Tangible Book Value Per Share17.5218.44717
Slightly volatile
Receivables Turnover1.211.651.0857
Slightly volatile
Shareholders Equity Per Share17.5518.47721
Slightly volatile
Debt To Equity0.280.220.3727
Slightly volatile
Capex Per Share0.00890.009435.7394
Slightly volatile
Graham Net Net5.45.69407
Slightly volatile
Average Receivables5.9 M3.6 M4.8 M
Pretty Stable
Revenue Per Share2.432.56425
Slightly volatile
Interest Debt Per Share4.024.2374.2265
Very volatile
Debt To Assets0.07210.10.0852
Pretty Stable
Graham Number1.5 K1.7 K1.9 K
Slightly volatile
Operating Cycle464423573
Pretty Stable
Price Book Value Ratio0.90.9556.72
Slightly volatile
Days Of Payables Outstanding237306313
Slightly volatile
Company Equity Multiplier3.111.914.5568
Slightly volatile
Long Term Debt To Capitalization0.00390.00750.0046
Slightly volatile
Total Debt To Capitalization0.190.180.2428
Slightly volatile
Debt Equity Ratio0.280.220.3727
Slightly volatile
Quick Ratio1.071.361.1377
Slightly volatile
Net Income Per E B T0.70.950.8497
Slightly volatile
Cash Ratio1.281.220.5547
Slightly volatile
Cash Conversion Cycle227117260
Very volatile
Days Of Inventory Outstanding136194183
Slightly volatile
Days Of Sales Outstanding327229390
Very volatile
Price To Book Ratio0.90.9556.72
Slightly volatile
Fixed Asset Turnover4.813.935.7036
Slightly volatile
Debt Ratio0.07210.10.0852
Pretty Stable
Price Sales Ratio6.536.8793.6437
Slightly volatile
Asset Turnover0.09110.09590.4094
Slightly volatile
Gross Profit Margin0.480.330.3631
Slightly volatile
Price Fair Value0.90.9556.72
Slightly volatile

China SXT Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap12.6 M13.2 M74.4 M
Slightly volatile
Enterprise Value2.3 M2.4 M69.6 M
Slightly volatile

China Fundamental Market Drivers

Cash And Short Term Investments12.1 M

China Upcoming Events

30th of October 2023
Upcoming Quarterly Report
View
30th of June 2023
Next Fiscal Quarter End
View

About China SXT Financial Statements

China SXT stakeholders use historical fundamental indicators, such as China SXT's revenue or net income, to determine how well the company is positioned to perform in the future. Although China SXT investors may analyze each financial statement separately, they are all interrelated. For example, changes in China SXT's assets and liabilities are reflected in the revenues and expenses on China SXT's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in China SXT Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue168.9 K192.3 K
Total Revenue1.7 M1.6 M
Cost Of Revenue1.2 M1.8 M
Stock Based Compensation To Revenue 0.21  0.20 
Sales General And Administrative To Revenue 1.23  0.72 
Revenue Per Share 2.56  2.43 
Ebit Per Revenue(1.50)(1.42)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce
When determining whether China SXT Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of China SXT's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of China Sxt Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on China Sxt Pharmaceuticals Stock:
How To Invest In China
Details
Is China Stock a good investment?
Details
What is China SXT's Net Worth?
Details
Largest Personal Care Products Companies
View
Largest Drug Manufacturers - Specialty & Generic Companies
View
Check out the analysis of China SXT Correlation against competitors.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China SXT. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China SXT listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.426
Earnings Share
(28.58)
Revenue Per Share
17.786
Quarterly Revenue Growth
0.295
Return On Assets
(0.05)
The market value of China SXT Pharmaceuticals is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China SXT's value that differs from its market value or its book value, called intrinsic value, which is China SXT's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China SXT's market value can be influenced by many factors that don't directly affect China SXT's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between China SXT's value and its price as these two are different measures arrived at by different means. Investors typically determine if China SXT is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China SXT's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY